Three years after Pfizer Inc. (NYSE:PFE) dropped a bombshell on its plans to lay off more than 1000 workers. The biopharmaceutical company has come back with some of the best news, on how it plans to use the vacated Groton site. In a joint announcement, Gov. Dannel P. Malloy and Pfizer confirmed that two buildings on the company’s campus will be donated for use in bioscience research as well as act as a storage site for state data. Pfizer Inc. (NYSE:PFE) shares after opening at $32.52 moved to $32.69 on last trade day and at the end of the day closed at $32.16. Company price to sales ratio in past twelve months was calculated as 3.99 and price to cash ratio as 6.34. Pfizer Inc. (NYSE:PFE) showed a positive weekly performance of 0.88%.
Merck & Co., Inc. (NYSE:MRK) wants to feed its controversial feed additive Zilmax to 240,000 U.S. cattle to prove it is safe. But there is a problem: giant meat processors like Cargill Inc don’t want to touch animals fed with the drug.Merck & Co., Inc. (NYSE:MRK) plans to conduct the biggest ever test of its kind in an effort to reintroduce the weight-adding drug into the United States and Canada after suspending sales last August. A test herd of this size is currently worth up to $500 million.Merck & Co., Inc. (NYSE:MRK) shares advanced -0.16% in last trading session and ended the day on $56.12. MRK return on equity ratio is recorded as 12.10% and its return on assets is 5.60%. Merck & Co., Inc. (NYSE:MRK) yearly performance is 31.77%.
It’s more bad news for Johnson & Johnson (NYSE:JNJ) Ethicon division in its ongoing vaginal mesh debacle. The company will have to pay out again, in these many cases to go to court over its allegedly defective transvaginal mesh products and urinary incontinence slings.Johnson & Johnson, the world’s biggest maker of medical products, was ordered by a Texas jury to pay $1.2 million to a woman who alleged that vaginal-mesh implants to treat incontinence was defectively designed. This was the first verdict against the company over those devices. Johnson & Johnson (NYSE:JNJ) shares moved up 0.16% in last trading session and was closed at $98.42, while trading in range of $98.32-$99.38. Johnson & Johnson (NYSE:JNJ) year to date performance is 8.23%.
Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the first quarter of 2014 on Tuesday, April 29, 2014. During a conference call at 9 a.m. EDT on April 29, company executives will review financial information and will address inquiries from investors and analysts. Bristol-Myers Squibb Co (NYSE:BMY) weekly performance is -3.05%. On last trading day company shares ended up $49.89. Bristol-Myers Squibb Co (NYSE:BMY) distance from 50-day simple moving average is -4.92%. Analysts mean target price for the company is $55.12.
Leave a Reply